UniProt ID | UBA6_HUMAN | |
---|---|---|
UniProt AC | A0AVT1 | |
Protein Name | Ubiquitin-like modifier-activating enzyme 6 | |
Gene Name | UBA6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1052 | |
Subcellular Localization | ||
Protein Description | Activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a ubiquitin-E1 thioester and free AMP. Specific for ubiquitin, does not activate ubiquitin-like peptides. Differs from UBE1 in its specificity for substrate E2 charging. Does not charge cell cycle E2s, such as CDC34. Essential for embryonic development. Required for UBD/FAT10 conjugation. Isoform 2 may play a key role in ubiquitin system and may influence spermatogenesis and male fertility.. | |
Protein Sequence | MEGSEPVAAHQGEEASCSSWGTGSTNKNLPIMSTASVEIDDALYSRQRYVLGDTAMQKMAKSHVFLSGMGGLGLEIAKNLVLAGIKAVTIHDTEKCQAWDLGTNFFLSEDDVVNKRNRAEAVLKHIAELNPYVHVTSSSVPFNETTDLSFLDKYQCVVLTEMKLPLQKKINDFCRSQCPPIKFISADVHGIWSRLFCDFGDEFEVLDTTGEEPKEIFISNITQANPGIVTCLENHPHKLETGQFLTFREINGMTGLNGSIQQITVISPFSFSIGDTTELEPYLHGGIAVQVKTPKTVFFESLERQLKHPKCLIVDFSNPEAPLEIHTAMLALDQFQEKYSRKPNVGCQQDSEELLKLATSISETLEEKPDVNADIVHWLSWTAQGFLSPLAAAVGGVASQEVLKAVTGKFSPLCQWLYLEAADIVESLGKPECEEFLPRGDRYDALRACIGDTLCQKLQNLNIFLVGCGAIGCEMLKNFALLGVGTSKEKGMITVTDPDLIEKSNLNRQFLFRPHHIQKPKSYTAADATLKINSQIKIDAHLNKVCPTTETIYNDEFYTKQDVIITALDNVEARRYVDSRCLANLRPLLDSGTMGTKGHTEVIVPHLTESYNSHRDPPEEEIPFCTLKSFPAAIEHTIQWARDKFESSFSHKPSLFNKFWQTYSSAEEVLQKIQSGHSLEGCFQVIKLLSRRPRNWSQCVELARLKFEKYFNHKALQLLHCFPLDIRLKDGSLFWQSPKRPPSPIKFDLNEPLHLSFLQNAAKLYATVYCIPFAEEDLSADALLNILSEVKIQEFKPSNKVVQTDETARKPDHVPISSEDERNAIFQLEKAILSNEATKSDLQMAVLSFEKDDDHNGHIDFITAASNLRAKMYSIEPADRFKTKRIAGKIIPAIATTTATVSGLVALEMIKVTGGYPFEAYKNCFLNLAIPIVVFTETTEVRKTKIRNGISFTIWDRWTVHGKEDFTLLDFINAVKEKYGIEPTMVVQGVKMLYVPVMPGHAKRLKLTMHKLVKPTTEKKYVDLTVSFAPDIDGDEDLPGPPVRYYFSHDTD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEGSEPVA -------CCCCCCCC | 51.88 | 19413330 | |
4 | Phosphorylation | ----MEGSEPVAAHQ ----CCCCCCCCCCC | 41.86 | 23186163 | |
16 | Phosphorylation | AHQGEEASCSSWGTG CCCCCCCCCCCCCCC | 20.15 | 25159151 | |
18 | Phosphorylation | QGEEASCSSWGTGST CCCCCCCCCCCCCCC | 26.99 | 23186163 | |
19 | Phosphorylation | GEEASCSSWGTGSTN CCCCCCCCCCCCCCC | 33.58 | 23186163 | |
22 | Phosphorylation | ASCSSWGTGSTNKNL CCCCCCCCCCCCCCC | 23.00 | 23186163 | |
24 | Phosphorylation | CSSWGTGSTNKNLPI CCCCCCCCCCCCCCE | 28.75 | 23186163 | |
29 (in isoform 2) | Ubiquitination | - | 3.04 | 21890473 | |
33 | Phosphorylation | NKNLPIMSTASVEID CCCCCEEEEEEEEEC | 22.88 | 26657352 | |
34 | Phosphorylation | KNLPIMSTASVEIDD CCCCEEEEEEEEECH | 12.93 | 21712546 | |
36 | Phosphorylation | LPIMSTASVEIDDAL CCEEEEEEEEECHHH | 21.99 | 21712546 | |
44 | Phosphorylation | VEIDDALYSRQRYVL EEECHHHHHCCCHHH | 11.97 | 28796482 | |
45 | Phosphorylation | EIDDALYSRQRYVLG EECHHHHHCCCHHHC | 23.84 | 28796482 | |
54 | Phosphorylation | QRYVLGDTAMQKMAK CCHHHCHHHHHHHHH | 23.41 | 28857561 | |
56 | Sulfoxidation | YVLGDTAMQKMAKSH HHHCHHHHHHHHHHC | 4.23 | 21406390 | |
58 | Ubiquitination | LGDTAMQKMAKSHVF HCHHHHHHHHHHCEE | 27.95 | - | |
61 | Ubiquitination | TAMQKMAKSHVFLSG HHHHHHHHHCEEHHC | 37.28 | - | |
70 (in isoform 2) | Ubiquitination | - | 31.53 | 21890473 | |
86 | Acetylation | NLVLAGIKAVTIHDT HHHHCCCEEEEECCC | 35.57 | 25953088 | |
95 | Ubiquitination | VTIHDTEKCQAWDLG EEECCCCCCCCCCCC | 33.47 | - | |
115 | Ubiquitination | SEDDVVNKRNRAEAV CHHHHHCCCHHHHHH | 39.17 | - | |
146 | Phosphorylation | SVPFNETTDLSFLDK CCCCCCCCCCHHHCC | 28.85 | - | |
149 | Phosphorylation | FNETTDLSFLDKYQC CCCCCCCHHHCCCCE | 26.94 | - | |
169 | Ubiquitination | MKLPLQKKINDFCRS CCCCHHHHHHHHHHH | 33.51 | - | |
170 (in isoform 2) | Ubiquitination | - | 8.45 | 21890473 | |
178 (in isoform 2) | Ubiquitination | - | 4.57 | 21890473 | |
182 | Ubiquitination | RSQCPPIKFISADVH HHHCCCCEEEEECCC | 42.28 | - | |
213 (in isoform 2) | Ubiquitination | - | 34.97 | 21890473 | |
238 | Ubiquitination | CLENHPHKLETGQFL EECCCCCCCCCCCEE | 53.09 | - | |
241 | Phosphorylation | NHPHKLETGQFLTFR CCCCCCCCCCEEEEE | 46.87 | - | |
246 | Phosphorylation | LETGQFLTFREINGM CCCCCEEEEEEECCC | 23.18 | - | |
255 (in isoform 2) | Ubiquitination | - | 14.30 | 21890473 | |
265 (in isoform 2) | Ubiquitination | - | 4.33 | 21890473 | |
295 | Ubiquitination | AVQVKTPKTVFFESL EEEEECCCCCCHHHH | 63.65 | 21906983 | |
295 (in isoform 1) | Ubiquitination | - | 63.65 | 21890473 | |
295 (in isoform 3) | Ubiquitination | - | 63.65 | 21906983 | |
295 (in isoform 4) | Ubiquitination | - | 63.65 | 21906983 | |
301 | Phosphorylation | PKTVFFESLERQLKH CCCCCHHHHHHHHCC | 30.30 | 23917254 | |
310 | Ubiquitination | ERQLKHPKCLIVDFS HHHHCCCCEEEEECC | 41.20 | - | |
326 (in isoform 2) | Ubiquitination | - | 9.74 | 21890473 | |
342 | Ubiquitination | FQEKYSRKPNVGCQQ HHHHHCCCCCCCCCC | 34.70 | - | |
356 (in isoform 2) | Ubiquitination | - | 49.01 | 21890473 | |
408 (in isoform 2) | Ubiquitination | - | 23.55 | 21890473 | |
415 (in isoform 2) | Ubiquitination | - | 40.67 | 21890473 | |
488 | Ubiquitination | LLGVGTSKEKGMITV EECCCCCCCCCCEEE | 64.38 | - | |
490 | Ubiquitination | GVGTSKEKGMITVTD CCCCCCCCCCEEECC | 58.47 | - | |
492 | Sulfoxidation | GTSKEKGMITVTDPD CCCCCCCCEEECCHH | 3.25 | 21406390 | |
503 | Ubiquitination | TDPDLIEKSNLNRQF CCHHHHHHCCCCCCC | 37.34 | 21906983 | |
503 (in isoform 1) | Ubiquitination | - | 37.34 | 21890473 | |
521 | Ubiquitination | PHHIQKPKSYTAADA HHHCCCCCCEECCCC | 64.23 | - | |
522 | Phosphorylation | HHIQKPKSYTAADAT HHCCCCCCEECCCCE | 35.92 | 30622161 | |
524 | Phosphorylation | IQKPKSYTAADATLK CCCCCCEECCCCEEE | 23.59 | 30622161 | |
529 | Phosphorylation | SYTAADATLKINSQI CEECCCCEEEECCEE | 29.18 | 25599653 | |
531 | Ubiquitination | TAADATLKINSQIKI ECCCCEEEECCEEEE | 35.17 | - | |
544 | Acetylation | KIDAHLNKVCPTTET EECEECCCCCCCCCC | 52.12 | 19608861 | |
544 | Ubiquitination | KIDAHLNKVCPTTET EECEECCCCCCCCCC | 52.12 | 21890473 | |
544 | Malonylation | KIDAHLNKVCPTTET EECEECCCCCCCCCC | 52.12 | 26320211 | |
544 (in isoform 1) | Ubiquitination | - | 52.12 | 21890473 | |
558 | Phosphorylation | TIYNDEFYTKQDVII CCCCCCCCCCCCEEE | 15.81 | 27642862 | |
560 | Ubiquitination | YNDEFYTKQDVIITA CCCCCCCCCCEEEEE | 32.87 | - | |
597 | Ubiquitination | DSGTMGTKGHTEVIV HCCCCCCCCCCEEEC | 42.86 | - | |
628 | Ubiquitination | EIPFCTLKSFPAAIE HCCCCEECCHHHHHH | 31.71 | 20639865 | |
629 | Phosphorylation | IPFCTLKSFPAAIEH CCCCEECCHHHHHHH | 39.31 | 28857561 | |
637 | Phosphorylation | FPAAIEHTIQWARDK HHHHHHHHHHHHHHH | 11.32 | 20068231 | |
644 | Ubiquitination | TIQWARDKFESSFSH HHHHHHHHHHHHHCC | 45.54 | 21890473 | |
644 (in isoform 1) | Ubiquitination | - | 45.54 | 21890473 | |
647 | Phosphorylation | WARDKFESSFSHKPS HHHHHHHHHHCCCHH | 39.55 | 26270265 | |
648 | Phosphorylation | ARDKFESSFSHKPSL HHHHHHHHHCCCHHH | 24.46 | 26270265 | |
650 | Phosphorylation | DKFESSFSHKPSLFN HHHHHHHCCCHHHHH | 32.33 | 26270265 | |
652 | Ubiquitination | FESSFSHKPSLFNKF HHHHHCCCHHHHHHH | 34.79 | 21890473 | |
652 (in isoform 1) | Ubiquitination | - | 34.79 | 21890473 | |
654 | Phosphorylation | SSFSHKPSLFNKFWQ HHHCCCHHHHHHHHH | 50.85 | 26270265 | |
662 | Phosphorylation | LFNKFWQTYSSAEEV HHHHHHHHCCCHHHH | 18.90 | 28857561 | |
664 | Phosphorylation | NKFWQTYSSAEEVLQ HHHHHHCCCHHHHHH | 26.85 | 28857561 | |
665 | Phosphorylation | KFWQTYSSAEEVLQK HHHHHCCCHHHHHHH | 29.32 | 28857561 | |
672 | Ubiquitination | SAEEVLQKIQSGHSL CHHHHHHHHHCCCCH | 38.25 | - | |
675 | Phosphorylation | EVLQKIQSGHSLEGC HHHHHHHCCCCHHHH | 41.78 | 30622161 | |
678 | Phosphorylation | QKIQSGHSLEGCFQV HHHHCCCCHHHHHHH | 31.48 | 30622161 | |
687 | Ubiquitination | EGCFQVIKLLSRRPR HHHHHHHHHHHCCCC | 44.51 | 21890473 | |
687 (in isoform 1) | Ubiquitination | - | 44.51 | 21890473 | |
697 | Phosphorylation | SRRPRNWSQCVELAR HCCCCCHHHHHHHHH | 19.76 | 28857561 | |
709 | Ubiquitination | LARLKFEKYFNHKAL HHHHHHHHHHCHHHH | 59.27 | - | |
714 | Ubiquitination | FEKYFNHKALQLLHC HHHHHCHHHHHHHHC | 52.47 | - | |
729 | Acetylation | FPLDIRLKDGSLFWQ EECEEEECCCCEEEC | 50.63 | - | |
729 | Ubiquitination | FPLDIRLKDGSLFWQ EECEEEECCCCEEEC | 50.63 | 21890473 | |
729 (in isoform 1) | Ubiquitination | - | 50.63 | 21890473 | |
732 | Phosphorylation | DIRLKDGSLFWQSPK EEEECCCCEEECCCC | 30.44 | 28857561 | |
737 | Phosphorylation | DGSLFWQSPKRPPSP CCCEEECCCCCCCCC | 24.00 | 25159151 | |
739 | Ubiquitination | SLFWQSPKRPPSPIK CEEECCCCCCCCCCC | 80.79 | 21890473 | |
739 (in isoform 1) | Ubiquitination | - | 80.79 | 21890473 | |
743 | Phosphorylation | QSPKRPPSPIKFDLN CCCCCCCCCCCCCCC | 41.77 | 29255136 | |
746 | Ubiquitination | KRPPSPIKFDLNEPL CCCCCCCCCCCCCCH | 35.89 | - | |
756 | Phosphorylation | LNEPLHLSFLQNAAK CCCCHHHHHHHHHHH | 17.11 | 23898821 | |
796 | Ubiquitination | EVKIQEFKPSNKVVQ HCCCEECCCCCCEEC | 46.94 | - | |
800 | Ubiquitination | QEFKPSNKVVQTDET EECCCCCCEECCCCC | 48.39 | 21890473 | |
800 (in isoform 1) | Ubiquitination | - | 48.39 | 21890473 | |
810 | Ubiquitination | QTDETARKPDHVPIS CCCCCCCCCCCCCCC | 52.94 | - | |
817 | Phosphorylation | KPDHVPISSEDERNA CCCCCCCCCHHHHHH | 22.93 | 20068231 | |
818 | Phosphorylation | PDHVPISSEDERNAI CCCCCCCCHHHHHHH | 50.19 | 28985074 | |
830 | Ubiquitination | NAIFQLEKAILSNEA HHHHHHHHHHHCCCC | 49.68 | 21890473 | |
830 (in isoform 1) | Ubiquitination | - | 49.68 | 21890473 | |
839 | Ubiquitination | ILSNEATKSDLQMAV HHCCCCCHHHHHHHE | 49.36 | - | |
871 | Ubiquitination | AASNLRAKMYSIEPA EHHHHHHHHCCCCCH | 31.75 | - | |
874 | Phosphorylation | NLRAKMYSIEPADRF HHHHHHCCCCCHHHH | 19.58 | 28857561 | |
882 | Ubiquitination | IEPADRFKTKRIAGK CCCHHHHCCHHHCCC | 54.77 | 21890473 | |
882 (in isoform 1) | Ubiquitination | - | 54.77 | 21890473 | |
889 | Ubiquitination | KTKRIAGKIIPAIAT CCHHHCCCHHCCHHC | 28.57 | 21890473 | |
889 (in isoform 1) | Ubiquitination | - | 28.57 | 21890473 | |
951 | Phosphorylation | TKIRNGISFTIWDRW CCCCCCCCEEEEECC | 20.10 | 28857561 | |
953 | Phosphorylation | IRNGISFTIWDRWTV CCCCCCEEEEECCEE | 17.86 | 29523821 | |
976 | Ubiquitination | LDFINAVKEKYGIEP HHHHHHHHHHHCCCC | 46.18 | - | |
978 | Ubiquitination | FINAVKEKYGIEPTM HHHHHHHHHCCCCCE | 42.96 | - | |
979 | Phosphorylation | INAVKEKYGIEPTMV HHHHHHHHCCCCCEE | 25.16 | 20068231 | |
984 | Phosphorylation | EKYGIEPTMVVQGVK HHHCCCCCEEEEEEE | 15.14 | 21406692 | |
994 | Phosphorylation | VQGVKMLYVPVMPGH EEEEEEEEEECCCCC | 10.14 | - | |
1003 | Acetylation | PVMPGHAKRLKLTMH ECCCCCHHHHEEEEE | 53.22 | 25953088 | |
1003 | Ubiquitination | PVMPGHAKRLKLTMH ECCCCCHHHHEEEEE | 53.22 | - | |
1003 | Malonylation | PVMPGHAKRLKLTMH ECCCCCHHHHEEEEE | 53.22 | 26320211 | |
1006 | Acetylation | PGHAKRLKLTMHKLV CCCHHHHEEEEEECC | 46.04 | 25953088 | |
1011 | Ubiquitination | RLKLTMHKLVKPTTE HHEEEEEECCCCCCC | 44.12 | - | |
1014 | Acetylation | LTMHKLVKPTTEKKY EEEEECCCCCCCCCE | 47.27 | 26210075 | |
1016 | Phosphorylation | MHKLVKPTTEKKYVD EEECCCCCCCCCEEE | 41.70 | 20068231 | |
1017 | Phosphorylation | HKLVKPTTEKKYVDL EECCCCCCCCCEEEE | 55.10 | 20068231 | |
1046 | Phosphorylation | PGPPVRYYFSHDTD- CCCCEEEEECCCCC- | 6.50 | 27642862 | |
1051 | Phosphorylation | RYYFSHDTD------ EEEECCCCC------ | 37.88 | 22617229 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBA6_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBA6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBA6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-544, AND MASS SPECTROMETRY. |